On Monday, Olema Pharmaceuticals Inc (NASDAQ: OLMA) opened lower -6.62% from the last session, before settling in for the closing price of $5.89. Price fluctuations for OLMA have ranged from $5.43 to $16.77 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -7.49% at the time writing. With a float of $42.88 million, this company’s outstanding shares have now reached $57.29 million.
The extent of productivity of a business whose workforce counts for 74 workers is very important to gauge. In terms of profitability, gross margin is 85.67%, operating margin of -7213.69%, and the pretax margin is -6511.62%.
Olema Pharmaceuticals Inc (OLMA) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Olema Pharmaceuticals Inc is 25.17%, while institutional ownership is 85.00%. The most recent insider transaction that took place on Dec 17 ’24, was worth 4,730,137. In this transaction Director of this company sold 700,761 shares at a rate of $6.75, taking the stock ownership to the 0 shares. Before that another transaction happened on Dec 13 ’24, when Company’s Affiliate proposed sale 700,761 for $6.75, making the entire transaction worth $4,730,137.
Olema Pharmaceuticals Inc (OLMA) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -7.49% per share during the next fiscal year.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Trading Performance Indicators
Check out the current performance indicators for Olema Pharmaceuticals Inc (OLMA). In the past quarter, the stock posted a quick ratio of 7.10.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.19, a number that is poised to hit -0.64 in the next quarter and is forecasted to reach -2.65 in one year’s time.
Technical Analysis of Olema Pharmaceuticals Inc (OLMA)
The latest stats from [Olema Pharmaceuticals Inc, OLMA] show that its last 5-days average volume of 1.42 million was superior to 1.09 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 18.05%. Additionally, its Average True Range was 0.65.
During the past 100 days, Olema Pharmaceuticals Inc’s (OLMA) raw stochastic average was set at 0.88%, which indicates a significant decrease from 5.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 70.73% in the past 14 days, which was lower than the 75.17% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.10, while its 200-day Moving Average is $11.12. Now, the first resistance to watch is $5.84. This is followed by the second major resistance level at $6.18. The third major resistance level sits at $6.36. If the price goes on to break the first support level at $5.32, it is likely to go to the next support level at $5.14. The third support level lies at $4.80 if the price breaches the second support level.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Key Stats
There are currently 57,298K shares outstanding in the company with a market cap of 408.34 million. Presently, the company’s annual sales total 0 K according to its annual income of -96,660 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -34,560 K.
